NLA GUIDELINES Bundle (free trial)

Dyslipidemia-II NLA

Official NLA Dyslipidemia Guidelines Appsbrought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 37 of 37

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations AA, African American; ACC, American College of Cardiolog y; AHA, American Heart Association; AI, American Indian; AN, Alaska Native; APO, apolipoprotein; ART, antiretroviral therapy; ASCVD, atherosclerotic cardiovascular disease; ATP, Adult Treatment Panel; AUC, area under the curve; BP, blood pressure; C, cholesterol; CHD, coronary heart disease; CKD, chronic kidney disease; DASH, Dietary Approaches to Stop Hypertension; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FDA, Food and Drug Administration; FH, familial hypercholesterolemia; FHx, family history; FLP, fasting lipid panel; FMP, final menstrual period; FPG, fasting plasma glucose; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; HgbA1c, glycated hemoglobin; HIV, human immunodeficiency virus; HT, hormone therapy; IDF, International Diabetes Federation; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; MNT, medical nutrition therapy; MUFA, monounsaturated fatty acid, PUFA, polyunsaturated fatty acid; NHW, non-Hispanic white; NIH, National Institutes of Health; NLA, National Lipid Association; PCOS, polycystic ovarian syndrome; RA, rheumatoid arthritis; RF, risk factor; SA, South Asian; T2DM, type 2 diabetes mellitus; TG, triglycerides; TC/Total-C, total cholesterol; USDA, United States Department of Agriculture; WC, waist circumference; y, year Source Jacobson TA, Maki KC, Orringer C, National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2, Journal of Clinical Lipidolog y (2015), doi: 10.1016/j.jacl.2015.09.002. Available at: assets/raw/Health%20Advance/journals/jacl/NLA_Recommendations_manuscript.pdf. Jacobson TA, Ito MK, Maki KC, Orringer CE, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – full report. J Clin Lipidol. 2015;9:129-169. Available at: 2874(15)00059-8/pdf. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at Copyright © 2016 All rights reserved NLADYS216063b

Articles in this issue

Links on this page

Archives of this issue

view archives of NLA GUIDELINES Bundle (free trial) - Dyslipidemia-II NLA